Plasma clearance and biodistribution of oxidatively modified 99mTc-ß-VLDL in rabbits

Brazilian Journal of Medical and Biological Research

Volumn 30, Issue 6, 1997, Pages 705-717

  Silva, E L ^a   Meneghetti, J C ^a   Coelho, I J C ^a   Abdalla, D S P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atherosclerosis; Biodistribution; Cholesterol feeding; Copper mediated oxidation; Fractional clearance rate; Hypercholesterolemia; Rabbit; very low density lipoprotein

Indexed keywords

ORYCTOLAGUS CUNICULUS;

LIPID; PERTECHNETIC ACID TC 99M; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL; ARTERIOSCLEROSIS; ARTICLE; BLOOD; ISOLATION AND PURIFICATION; MACROPHAGE ACTIVATION; MALE; METABOLIC CLEARANCE RATE; METABOLISM; PHYSIOLOGY; RABBIT; TISSUE DISTRIBUTION;

ANIMALS; ARTERIOSCLEROSIS; LIPIDS; LIPOPROTEINS, VLDL; MACROPHAGE ACTIVATION; MALE; METABOLIC CLEARANCE RATE; RABBITS; SODIUM PERTECHNETATE TC 99M; TISSUE DISTRIBUTION;

EID: 0031158082     PISSN: 0100879X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0100-879X1997000600002     Document Type: Article

References (43)

1. Mahley RW (1983). Development of accelerated atherosclerosis: concepts derived from cell biology and animal model studies. Archives of Pathology and Laboratory Medicine, 107: 393-399.
2. Witztum JL (1994). The oxidation hypothesis of atherosclerosis. Lancet, 344: 793-795.
3. Morel DW, DiCorleto PE & Chilson GM (1984). Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis, 4: 357-364.
4. Hiramatsu K, Rosen H, Heinecke JW, Wolfbauer G & Chait A (1987). Superoxide initiates oxidation of low density lipoprotein by human monocytes. Arteriosclerosis, 7: 55-60.
5. Abdalla DSP, Campa A & Monteiro HP (1992). Low density lipoprotein oxidation by stimulated neutrophils and ferritin. Atherosclerosis, 97: 149-159.
6. Jessup W, Darley-Usmar VM, O'Leary VJ & Bedwell S (1991). 5-Lipoxygenase is not essential in macrophage-mediated oxidation of low-density lipoprotein. Biochemical Journal, 278: 163-169.
7. Parthasarathy S (1994). Mechanisms of oxidation of LDL. In: Parthasarathy S (Editor), Modified Lipoproteins in the Pathogenesis of Atherosclerosis. R.G. Landes Company, Austin, 91-119.
8. Halliwell B & Gutteridge JMC (1985). The importance of free radicals and catalytic metal ions in human diseases. Molecular Aspects of Medicine, 8: 89-193.
9. Brown MS & Goldstein JL (1986). A receptor-mediated pathway for cholesterol homeostasis. Science, 232: 34-47.
10. 2-macroglobulin receptor and epithelial glycoprotein-330: two giant receptors mediating endocytosis of multiple ligands. Biochimica et Biophysica Acta, 1197: 197-213.
11. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W & Witztum J (1992). Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet, 339: 883-891.
12. Virella G, Virella I, Leman RB, Pryor MB & Virella MFL (1993). Anti-oxidized low density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. International Journal of Clinical and Laboratory Research, 23: 95-101.
13. Silva EL, Moriel P, Chang YH & Abdalla DSP (1995). Plasma antioxidant enzymes and oxidized lipoproteine in hypercholesterolemic rabbits. Biochemical and Molecular Biology International, 36: 679-687.
14. Leitha T, Hermann M, Hüttinger M, Angelberger P & Dudczack R (1993). Technetium-99m labelled LDL as a tracer for quantitative LDL scintigraphy. I. Tracer purification, in vitro and in vivo long-term stability, in vitro validation and biodistribution. European Journal of Nuclear Medicine, 20: 667-673.
15. Havel RJ, Eder HA & Bradgon HJ (1955). The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. Journal of Clinical Investigation, 34: 1345-1353.
16. Lees RS, Garabedian HD & Lees AM (1985). Technetium-99m low density lipoprotein preparation and biodistnbution. Journal of Nuclear Medicine, 26: 1056-1062.
17. 131I-labeled plasma proteins. Physics in Medicine and Biology, 2: 36-56.
18. Boyum A (1968). Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one g centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 g. Scandinavian Journal of Laboratory Investigation, 21: 77-81.
19. Lowry OH, Rosebrough NJ, Farr AL & Randall RJ (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193: 265-269.
20. 2. Free Radical Biology and Medicine, 1: 43-49.
21. Terao J, Shibata SS & Matsushita S (1988). Selective quantification of arachidonic acid hydroperoxides and their hydroxy derivatives in reverse-phase high performance liquid chromatography. Analytical Biochemistry, 169: 415-423.
22. Terao J, Asano I & Matsushita S (1985). Preparation of hydroperoxy and hydroxy derivatives of rat liver phosphatidylcholine and phosphatidylethanolamine. Lipids, 20: 312-317.
23. Levine RL, Garland D, Oliver CN, Amici S, Climent I, Lenz A-G, Ahn B-W, Shaltel S & Stadtman ER (1990). Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology, 186: 464-478.
24. Elman GE (1935). Tissue sulphydryl groups. Archives of Biochemistry and Biophysics, 82: 70-79.
25. Parthasarathy S, Quinn MT, Scwenke DC, Carew TE & Steinberg D (1989). Oxidative modification of beta-very low density lipoprotein. Arteriosclerosis, 9: 398-404.
26. Steinbrecher UP, Witztum JJ, Parthasarathy S & Steinberg D (1987). Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Arteriosclerosis, 7: 135-143.
27. 99mTc-Low density lipoprotein: intracellularly trapped radiotracer for noninvasive imaging of low density lipoprotein metabolism in vivo. Seminars in Nuclear Medicine, 1: 68-79.
28. Asai K, Hayashi T, Funaki C, Kuzuya M, Naito M & Kuzuya F (1991). Comparison of plasma clearance of low density lipoprotein with β-very low density lipoprotein or acetoacetylated low density lipoprotein in cholesterol-fed rabbits. Biochemistry International, 23: 327-334.
29. Kovanen PT, Brown MS, Basu K, Bilheimer DW & Goldstein JL (1981). Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits. Proceedings of the National Academy of Sciences, USA, 78: 1396-1400.
30. Gudmundsen O, Berg T, Roos N & Nenseter MS (1993). Hepatic uptake of β-VLDL in cholesterol-fed rabbits. Journal of Lipid Research, 34: 589-600.
31. Rijke YB, Hessels MAJ & Berkel TJC (1992). Recognition sites on rat liver cells for oxidatively modified β-very low density lipoproteins. Arteriosclerosis and Thrombosis, 12: 41-49.
32. Arai H, Kita T, Yokode M, Narumiya S & Kawai C (1989). Multiple receptors for modified LDL in mouse peritoneal macrophages: Different uptake mechanisms for acetylated and oxidized LDL. Biochemical and Biophysical Research Communications, 150: 1375-1382.
33. Sparrow CP, Parthasarathy S & Steinberg D (1989). A macrophage receptor that recognized oxidized LDL but not acetylated LDL. Journal of Biological Chemistry, 264: 2599-2604.
34. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL & Steinberg D (1989). Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. Journal of Clinical Investigation. 84: 1086-1095.
35. Geng Y, Kodama T & Hansson GK (1994). Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arteriosclerosis and Thrombosis, 14: 798-806.
36. Haberland ME, Olch CL & Fogelman AM (1984). Role of lysines in mediating interaction of modified low density lipoproteins with the scavenger receptor of human monocyte macrophages. Journal of Biological Chemistry, 259: 11305-11311.
37. Simionescu N, Vasile E, Lupu F, Popescu G & Simionescu M (1986). Prelesional events in atherogenesis. American Journal of Pathology. 123: 109-125.
38. Vasile E, Simionescu M & Simionescu N (1983). Visualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in the arterial endothelium in situ. Journal of Cell Biology. 96: 1677-1689.
39. 99mTechnetium-labeled low density lipoprotein: receptor recognition and intracellular sequestration of radiolabel. Journal of Lipid Research, 32: 1-8.
40. Hara H, Tanishita H, Yokoyama S, Tajima S & Yamamoto A (1987). Induction of acetylated low density lipoprotein receptor and suppression of low density lipoprotein receptor on the cells of human monocytic leukemia cell line (THP-1 cell). Biochemical and Biophysical Research Communications, 146: 802-808.
41. Ali KSM, Vallabhajosula S, Censi C, Lipszyc H, Lee H, Machac J, Violi F & Luliano L (1993). Biodistribution and imaging of Tc-99m-native and oxidized-LDL. Journal of Nuclear Medicine. 34: 67P (Abstract).
42. Horrigan S, Campbell JH & Campbell GR (1991). Effect of endothelial cells on 15-very low density lipoprotein by endothelial cells enhances its metabolism by smooth muscle cells in culture. Arteriosclerosis and Thrombosis, 11: 279-289.
43. Chisolm GM (1993). Oxidized lipoproteins and leukocyte-endothelial interactions: growing evidence for multiple mechanisms. Laboratory Investigation, 68: 369-371.